← Back to headlines
Candel Therapeutics and Cellectar Biosciences Miss EPS Estimates
Candel Therapeutics reported a GAAP EPS of -$0.52, missing estimates by $0.29, while Cellectar Biosciences reported a GAAP EPS of -$0.57, missing by $0.05.
13 Aug, 12:12 — 13 Aug, 12:12
Sources
Showing 1 of 1 sources
Related Stories
Japan’s Foreign Reserves Plunge Record Amount After Yen Intervention
19m ago
Amazon Cargo Plane Overruns Runway at Miami Airport, Killing Five
24m ago
Adidas Faces Boycott Calls Over Ad Featuring Amputee Former Israeli Soldier
2h ago
UK Chancellor Healey outlines growth strategy amid market concerns
5h ago